Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
- Pricing
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersHematology & Oncology Physician in Louisville, KY
NPI: 1043502206Primary Practice Location
Norton Women's and Children's Hospital
4001 Dutchmans Ln, Louisville, Kentucky, 40207
HQ Phone
Get M.D. Joseph's Phone NumberMobile
Get M.D. Joseph's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardKY State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 329 | 705 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 171 | 340 |
| 3 | 99223Initial hospital inpatient care, typically 70 minutes per day | 140 | 197 |
| 4 | 99205New patient office or other outpatient visit, typically 60 minutes | 73 | 73 |
| 5 | 99443Physician telephone patient service, 21-30 minutes of medical discussion | 71 | 98 |
Authors: Olatoyosi Odenike, Aref Al-Kali, Aditi Shastri, Salman Fazal, Gail Roboz, James Mccloskey, Casey O'Connell, Harold Keer, Amy Dezern, Amer Zeidan
Journal: Future Oncol
Publication Date: 2025-03-06
Pembrolizumab in classical Hodgkin's lymphoma.
Authors: Joseph Maly, Lapo Alinari
Publication Date: 2016-04-13
Advancing Precision Nuclear Medicine and Molecular Imaging for Lymphoma.
Authors: Wright, Chadwick L, Maly, Joseph J, Zhang, Jun, Knopp, Michael V
Journal: PET Clin
Publication Date: 2016-10-06
Lead Sponsor: Joseph M. Flynn, D.O., MPH
Intervention / Treatment: BIOLOGICAL: Convalescent Plasma
Lead Sponsor: Astex Pharmaceuticals, Inc.
Intervention / Treatment: DRUG: TAS1553
Lead Sponsor: Ono Pharmaceutical Co. Ltd
Intervention / Treatment: DRUG: ONO-7475 3mg once daily, DRUG: ONO-7475 6mg once daily, DRUG: ONO-7475 10mg once daily, DRUG: ONO-7475 6mg + Venetoclax (70-400mg)
